SOP 22.041
ASEPTIC PREPARATION OF GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
Home > Staff & Recruitment >
Staff & Recruitment
SOP 22.040
SAFE HANDLING OF SPILLAGE, PERSONAL CONTAMINATION OR INJURY INVOLVING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
Core Brief – 23 April 2024 (Daily update, 1.15pm)
Topics in this Core Brief: Think before you flush & Fresenius-Kabi volumetric and syringe pumps – adult In-patient areas, theatres and departments.
Core Brief – 22 April 2024 (Daily update, 2.40pm)
Topics in this Core Brief: Watch Your Waste pop-up stalls; Demystifying Death Week 2024: 6 – 12 May; and Travel update.
Core Brief – 19 April 2024 (Chief Executive, 2.30pm)
In this issue Jane talks about: a formal pause on the prescribing of puberty hormone suppressants and gender-affirming hormones to young people, RCN Nurse of…
Core Brief – 18 April 2024 (Daily update, 12.45pm)
Topics in this Core Brief: Uniform policy and hand hygiene measures
Core Brief – 17 April 2024 (Daily update, 3.45pm)
Topics in this Core Brief: Sharing how you and your team have involved and engaged patients and carers.
Schedule of Accreditation
UKAS Schedule of Accreditation
Uncertainty of Measurement Summary Table for Specialist Techniques
For acetylcholine receptor antibodies, GAD antibodies (for diabetes and Stiff Persons’ Syndrome), intrinsic factor antibodies and functional antibodies.